Resultats de la cerca - Saggese, Matilde

Advanced gastric cancer: Is there enough evidence to call second-line therapy standard? per Arkenau, Hendrik-Tobias, Saggese, Matilde, Lemech, Charlotte

Obtenir text complet Obtenir text complet Obtenir text complet

Research Biopsies in the Context of Early Phase Oncology Studies: Clinical and Ethical Considerations per Saggese, Matilde, Dua, Divyanshu, Simmons, Emily, Lemech, Charlotte, Arkenau, Hendrik-Tobias

Obtenir text complet Obtenir text complet Obtenir text complet

Interleukin-10 Expression in Macrophages during Phagocytosis of Apoptotic Cells Is Mediated by the TALE homeoproteins Pbx-1 and Prep-1 per Chung, Elaine Y., Liu, Jianguo, Homma, Yoichiro, Zhang, Yunhua, Brendolan, Andrea, Saggese, Matilde, Han, Jihong, Silverstein, Roy, Selleri, Licia, Ma, Xiaojing

Obtenir text complet Obtenir text complet Obtenir text complet

Osimertinib Versus Comparator EGFR TKI as First-Line Treatment for EGFR-Mutated Advanced NSCLC: FLAURA China, A Randomized Study per Cheng, Ying, He, Yong, Li, Wei, Zhang, He-long, Zhou, Qing, Wang, Buhai, Liu, Chunling, Walding, Andrew, Saggese, Matilde, Huang, Xiangning, Fan, Minhao, Wang, Jia, Ramalingam, Suresh S.

Obtenir text complet Obtenir text complet Obtenir text complet

A phase I/II study of epertinib plus trastuzumab with or without chemotherapy in patients with HER2-positive metastatic breast cancer per Macpherson, Iain R., Spiliopoulou, Pavlina, Rafii, Saeed, Saggese, Matilde, Baird, Richard D., Garcia-Corbacho, Javier, Italiano, Antoine, Bonneterre, Jacques, Campone, Mario, Cresti, Nicola, Posner, John, Takeda, Yousuke, Arimura, Akinori, Spicer, James

Obtenir text complet Obtenir text complet Obtenir text complet

Congenital Asplenia in Mice and Humans with Mutations in a Pbx/Nkx2-5/p15 Module per Koss, Matthew, Bolze, Alexandre, Brendolan, Andrea, Saggese, Matilde, Capellini, Terence D., Bojilova, Ekaterina, Boisson, Bertrand, Prall, Owen W.J., Elliott, David, Solloway, Mark, Lenti, Elisa, Hidaka, Chisa, Chang, Ching-Pin, Mahlaoui, Nizar, Harvey, Richard P., Casanova, Jean-Laurent, Selleri, Licia

Obtenir text complet Obtenir text complet Obtenir text complet

Tissue and Plasma EGFR Mutation Analysis in the FLAURA Trial: Osimertinib versus Comparator EGFR Tyrosine Kinase Inhibitor as First-Line Treatment in Patients with EGFR-Mutated Adv... per Gray, Jhanelle E., Okamoto, Isamu, Sriuranpong, Virote, Vansteenkiste, Johan, Imamura, Fumio, Lee, Jong Seok, Pang, Yong-Kek, Cobo, Manuel, Kasahara, Kazuo, Cheng, Ying, Nogami, Naoyuki, Cho, Eun Kyung, Su, Wu Chou, Zhang, Guili, Huang, Xiangning, Li-Sucholeiki, Xiaocheng, Lentrichia, Brian, Dearden, Simon, Jenkins, Suzanne, Saggese, Matilde, Rukazenkov, Yuri, Ramalingam, Suresh S.

Obtenir text complet Obtenir text complet Obtenir text complet